An expert discusses how rilzabrutinib’s covalent reversible binding mechanism provides a favorable safety profile with only manageable grade 1 to 2 toxicities and no cardiovascular or bleeding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback